|
Symbol Name ID |
Irs3
insulin receptor substrate 3 MGI:1194882 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Irs1tm1Jos/Irs1tm1Jos Irs3tm1Lhd/Irs3tm1Lhd involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 |
abnormal gonadal fat pad morphology | J:80976 |
| decreased circulating free fatty acids level | J:80976 | |
| decreased circulating leptin level | J:80976 | |
| decreased circulating triglyceride level | J:80976 | |
| decreased triglyceride level | J:80976 | |
| decreased white adipose tissue amount | J:80976 | |
| hyperglycemia | J:80976 | |
| impaired glucose tolerance | J:80976 | |
| increased circulating insulin level | J:80976 | |
| increased pancreatic beta cell mass | J:80976 | |
| insulin resistance | J:80976 | |
| normal liver/biliary system phenotype | J:80976 | |
| normal mortality/aging | J:80976 | |
| pancreatic islet hyperplasia | J:80976 | |
| postnatal growth retardation | J:80976 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/30/2025 MGI 6.24 |
|
|
|
||